Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Baxter
Mallinckrodt
Medtronic
McKesson
Colorcon
Harvard Business School

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

Litigation Details for Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)

See Plans and Pricing

« Back to Dashboard

Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)

Docket   Start Trial Date Filed 2017-11-22
Court District Court, D. Delaware Date Terminated 2019-05-08
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties AUROBINDO PHARMA USA, INC.; ONYX THERAPEUTICS, INC.
Patents 7,232,818; 7,417,042; 7,491,704; 7,737,112; 8,129,346; 8,207,125; 8,207,126; 8,207,127; 8,207,297; 9,173,857
Attorneys Arthur G. Connolly , III; Jack B. Blumenfeld; Mary I. Akhimien; Maryellen Noreika; Megan Elizabeth Dellinger; Steven J. Moore
Firms Connolly Gallagher LLP; Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .
Biologic Drugs cited in Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc.
The biologic drug covered by the patents cited in this case is   Start Trial .

Details for Onyx Therapeutics, Inc. v. Aurobindo Pharma USA, Inc. (D. Del. 2017)

Date Filed Document No. Description Snippet Link To Document
0000-00-00 and Covenant Not to Sue Regarding U.S. Patent Nos. 7,232,818; 7,491,704; 8,129,346; and 8,207,297 filed…November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 1 11. United States Patent No. 7,232,818 (the “’818 Patent”), entitled “Compounds For Enzyme Inhibition…Product prior to the expiration of U.S. Patent Nos. 7,417,042; 7,232,818; 7,491,704; 7,737,112; 8,129,346;… COUNT II: INFRINGEMENT OF U.S. PATENT NO. 7,232,818 47. Plaintiff hereby realleges… THE PATENTS-IN-SUIT 10. United States Patent No. 7,417,042 (the “’042 Patent”), entitled… This is a civil action for patent infringement under the patent laws of the United States, Title External link to document
0000-00-00 15 and Covenant Not to Sue Regarding U.S. Patent Nos. 7,232,818; 7,491,704; 8,129,346; and 8,207,297 by …November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 24 Order enjoined from infringing United States Patent Numbers 7,417,042, 7,737, 112, and 8,207,125, on its own…November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
0000-00-00 4 Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,173,857 B2; 7,232,818 B2; 7,491,704…November 2017 8 May 2019 1:17-cv-01699 835 Patent - Abbreviated New Drug Application(ANDA) External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Express Scripts
Johnson and Johnson
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.